ADC Therapeutics SA — All Filings
402 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
20-F
3
3/A
4
424B3
424B4
424B5
424B7
6-K
8-A12B
8-K
ARS
CERT
CORRESP
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
F-1
F-1/A
F-1MEF
F-3
F-3ASR
FWP
POS AM
POS EX
PRE 14A
RW
S-3
S-3/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-C
SC TO-I
SC TO-I/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 6-K | FORM 6-K | 0000950103-21-008577 | Jun 9, 2021 | — |
| 6-K | FORM 6-K | 0000950103-21-008426 | Jun 4, 2021 | — |
| F-3ASR | FORM F-3ASR | 0000950103-21-008434 | Jun 4, 2021 | — |
| 6-K | FORM 6-K | 0000950103-21-008204 | Jun 1, 2021 | — |
| F-3ASR | FORM F-3ASR | 0000950103-21-008214 | Jun 1, 2021 | — |
| 6-K | FORM 6-K | 0000950103-21-007935 | May 27, 2021 | — |
| 6-K | FORM 6-K | 0000950103-21-007856 | May 26, 2021 | — |
| 6-K | FORM 6-K | 0000950103-21-007508 | May 20, 2021 | May 19, 2021 |
| 6-K | FORM 6-K | 0000950103-21-007280 | May 17, 2021 | — |
| 6-K | FORM 6-K | 0000950103-21-007083 | May 12, 2021 | May 5, 2021 |
| 6-K | 6-K | 0001771910-21-000026 | May 6, 2021 | Mar 31, 2021 |
| 6-K | FORM 6-K | 0000950103-21-006812 | May 6, 2021 | May 5, 2021 |
| S-8 | FORM S-8 | 0000950103-21-006862 | May 6, 2021 | — |
| 6-K | FORM 6-K | 0000950103-21-006627 | May 4, 2021 | — |
| 6-K | FORM 6-K | 0000950103-21-006306 | Apr 29, 2021 | — |
| 6-K | FORM 6-K | 0000950103-21-005991 | Apr 23, 2021 | — |
| 6-K | FORM 6-K | 0000950103-21-005574 | Apr 14, 2021 | — |
| SC 13G/A | — | 0000315066-21-001495 | Apr 12, 2021 | — |
| 6-K | FORM 6-K | 0000950103-21-005260 | Apr 6, 2021 | — |
| 20-F | 20-F | 0001771910-21-000010 | Mar 18, 2021 | Dec 31, 2020 |
| 6-K | FORM 6-K | 0000950103-21-004189 | Mar 18, 2021 | — |
| 6-K | 6-K | 0001771910-21-000014 | Mar 18, 2021 | Dec 31, 2020 |
| 6-K | FORM 6-K | 0000950103-21-003816 | Mar 11, 2021 | — |
| 6-K | FORM 6-K | 0000950103-21-002956 | Feb 25, 2021 | — |
| SC 13G | SC 13G | 0001104659-21-023903 | Feb 16, 2021 | — |
| SC 13G/A | — | 0000315066-21-000809 | Feb 8, 2021 | — |
| 6-K | FORM 6-K | 0000950103-21-001846 | Feb 5, 2021 | — |
| 6-K | FORM 6-K | 0000950103-21-001777 | Feb 4, 2021 | — |
| 6-K | FORM 6-K | 0000950103-21-000171 | Jan 7, 2021 | — |
| 6-K | FORM 6-K | 0000950103-21-000002 | Jan 4, 2021 | — |
| 6-K | FORM 6-K | 0000950103-20-024142 | Dec 14, 2020 | — |
| SC 13G | — | 0000315066-20-001956 | Dec 10, 2020 | — |
| 6-K | FORM 6-K | 0000950103-20-023876 | Dec 7, 2020 | — |
| 6-K | FORM 6-K | 0000950103-20-023250 | Nov 30, 2020 | — |
| 6-K | FORM 6-K | 0000950103-20-022592 | Nov 20, 2020 | — |
| 6-K | FORM 6-K | 0000950103-20-022021 | Nov 12, 2020 | — |
| 6-K | FORM 6-K | 0000950103-20-021885 | Nov 10, 2020 | — |
| 6-K | FORM 6-K | 0000950103-20-021534 | Nov 5, 2020 | — |
| 6-K | FORM 6-K | 0000950103-20-021486 | Nov 4, 2020 | — |
| 6-K | FORM 6-K | 0000950103-20-021302 | Nov 3, 2020 | — |
| 6-K | FORM 6-K | 0000950103-20-021109 | Oct 30, 2020 | — |
| SC 13D/A | — | 0001011438-20-000196 | Oct 13, 2020 | — |
| 6-K | — | 0001771910-20-000016 | Oct 9, 2020 | — |
| 424B4 | 424B4 | 0001140361-20-021566 | Sep 25, 2020 | — |
| POS EX | POS EX | 0001140361-20-021371 | Sep 24, 2020 | — |
| 6-K | — | 0001771910-20-000015 | Sep 24, 2020 | Sep 23, 2020 |
| EFFECT | — | 9999999995-20-002552 | Sep 23, 2020 | — |
| 6-K | — | 0001771910-20-000014 | Sep 21, 2020 | — |
| CORRESP | — | 0001140361-20-021004 | Sep 21, 2020 | — |
| CORRESP | — | 0001140361-20-021001 | Sep 21, 2020 | — |